EA199800764A1 - Способ лечения или предупреждения макулярного отека или возрастной макулярной дистрофии - Google Patents

Способ лечения или предупреждения макулярного отека или возрастной макулярной дистрофии

Info

Publication number
EA199800764A1
EA199800764A1 EA199800764A EA199800764A EA199800764A1 EA 199800764 A1 EA199800764 A1 EA 199800764A1 EA 199800764 A EA199800764 A EA 199800764A EA 199800764 A EA199800764 A EA 199800764A EA 199800764 A1 EA199800764 A1 EA 199800764A1
Authority
EA
Eurasian Patent Office
Prior art keywords
makular
age
dystrophy
estimation
prevention
Prior art date
Application number
EA199800764A
Other languages
English (en)
Other versions
EA001681B1 (ru
Inventor
Уильям Эрик Спонсел
Элон Хэррис
Original Assignee
Эдванст Рисерч Энд Текнолоджи Инститьют
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605642.9A external-priority patent/GB9605642D0/en
Application filed by Эдванст Рисерч Энд Текнолоджи Инститьют filed Critical Эдванст Рисерч Энд Текнолоджи Инститьют
Publication of EA199800764A1 publication Critical patent/EA199800764A1/ru
Publication of EA001681B1 publication Critical patent/EA001681B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Раскрывается способ лечения и/или предупреждения макулярного отека и макулярной дистрофии, связанной с возрастом, который включает локальное введение карбоангидразных ингибиторов в глаз.Отчёт о международном поиске опубликован 1997.09.25.
EA199800764A 1996-02-26 1997-02-25 Способ лечения или предупреждения макулярного отека или возрастной макулярной дистрофии EA001681B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1225096P 1996-02-26 1996-02-26
GBGB9605642.9A GB9605642D0 (en) 1996-03-18 1996-03-18 Treatment of macular edema
PCT/US1997/002874 WO1997030704A2 (en) 1996-02-26 1997-02-25 Use of carbonic anhydrase inhibitors for treating macular edema

Publications (2)

Publication Number Publication Date
EA199800764A1 true EA199800764A1 (ru) 1999-06-24
EA001681B1 EA001681B1 (ru) 2001-06-25

Family

ID=26308946

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800764A EA001681B1 (ru) 1996-02-26 1997-02-25 Способ лечения или предупреждения макулярного отека или возрастной макулярной дистрофии

Country Status (26)

Country Link
EP (1) EP0954305B9 (ru)
JP (1) JP4392481B2 (ru)
KR (1) KR100471586B1 (ru)
CN (1) CN1225582A (ru)
AT (1) ATE239468T1 (ru)
AU (1) AU727565B2 (ru)
BG (1) BG64525B1 (ru)
BR (1) BR9707674A (ru)
CA (1) CA2247063C (ru)
CZ (1) CZ299509B6 (ru)
DE (1) DE69721824T2 (ru)
DK (1) DK0954305T3 (ru)
EA (1) EA001681B1 (ru)
EE (1) EE03804B1 (ru)
ES (1) ES2199348T4 (ru)
HU (1) HU227161B1 (ru)
IL (1) IL125912A0 (ru)
IS (1) IS2053B (ru)
MX (1) MXPA98006961A (ru)
NO (1) NO320043B1 (ru)
NZ (1) NZ331843A (ru)
PT (1) PT954305E (ru)
SK (1) SK284371B6 (ru)
TR (1) TR199801665T2 (ru)
WO (1) WO1997030704A2 (ru)
YU (1) YU49422B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
CA2323749A1 (en) * 1998-03-06 1999-09-10 William E. Sponsel Composition and method for treating macular disorders
US5948801A (en) * 1998-03-09 1999-09-07 Alcon Laboratories, Inc. Treatment of retinal edema with brinzolamide
JP2002520287A (ja) * 1998-07-10 2002-07-09 ザ・ユニバーシティ・オブ・シドニー 黄斑変性における血管新生の予防的治療
GB9902453D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902459D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB0000625D0 (en) 2000-01-13 2000-03-01 Zeneca Ltd Chemical compounds
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
EP2097421A2 (en) 2006-12-15 2009-09-09 Nicox S.A. Carbonic anhydrase inhibitors derivatives
AR084194A1 (es) * 2010-12-09 2013-04-24 Fovea Pharmaceuticals Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos
EP3559005A1 (en) 2016-12-21 2019-10-30 Biotheryx Inc. Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
GB2223166B (en) * 1988-09-29 1992-03-18 American Cyanamid Co Stable ophthalmic preparations containing methazolamide
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors

Also Published As

Publication number Publication date
CA2247063A1 (en) 1997-08-28
KR100471586B1 (ko) 2005-07-11
EE9800263A (et) 1999-08-16
EP0954305B1 (en) 2003-05-07
MXPA98006961A (es) 2004-11-19
NZ331843A (en) 2000-09-29
YU49422B (sh) 2006-01-16
WO1997030704A2 (en) 1997-08-28
PT954305E (pt) 2003-09-30
CN1225582A (zh) 1999-08-11
HUP9902054A3 (en) 2001-07-30
EP0954305B9 (en) 2010-08-04
EE03804B1 (et) 2002-08-15
EA001681B1 (ru) 2001-06-25
BR9707674A (pt) 2000-01-04
EP0954305A2 (en) 1999-11-10
IL125912A0 (en) 1999-04-11
DK0954305T3 (da) 2003-08-25
JP4392481B2 (ja) 2010-01-06
AU1972197A (en) 1997-09-10
SK115198A3 (en) 2000-01-18
BG64525B1 (bg) 2005-06-30
NO320043B1 (no) 2005-10-17
ES2199348T4 (es) 2010-10-19
DE69721824T2 (de) 2004-03-11
HUP9902054A1 (hu) 2000-03-28
JP2000506833A (ja) 2000-06-06
IS4829A (is) 1998-08-20
TR199801665T2 (xx) 1998-12-21
NO983906L (no) 1998-10-19
DE69721824D1 (de) 2003-06-12
NO983906D0 (no) 1998-08-25
YU35398A (sh) 2001-12-26
ATE239468T1 (de) 2003-05-15
CZ269998A3 (cs) 2000-01-12
CZ299509B6 (cs) 2008-08-20
KR19990087242A (ko) 1999-12-15
WO1997030704A3 (en) 1997-09-25
IS2053B (is) 2005-10-14
AU727565B2 (en) 2000-12-14
SK284371B6 (sk) 2005-02-04
CA2247063C (en) 2004-01-06
ES2199348T3 (es) 2004-02-16
HU227161B1 (en) 2010-09-28
BG102797A (en) 1999-09-30

Similar Documents

Publication Publication Date Title
EA199800764A1 (ru) Способ лечения или предупреждения макулярного отека или возрастной макулярной дистрофии
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
FR12C0004I1 (ru)
DE69526311T2 (de) Verwendung von Rapamycin zur Behandlung von Anämie
DE69434511D1 (de) Botulinumtoxin zur Behandlung von Dystonie
ATE166786T1 (de) Rapamycin zur behandlung von morbus crohn, ulcerativer colitis und ulcerative proctitis
DE69429369D1 (de) Verfahren und mittel zur behandlung abnormaler zustände des epitheliums von körperöffnungen
DE69521620T2 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
EA199700087A1 (ru) Способ ингибирования катепсина к
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
ES2127396T3 (es) Inhibidores aromaticos de acetilcolinesterasa.
DE69018045D1 (de) Pfropfcopolymer, das Pfropfcopolymer enthaltende Lösung und Verfahren zum Behandeln von Kontaktlinsen.
DE69502157D1 (de) Stabilisation von getränke
DE69405711T2 (de) Behandlung von rueckstandsoel
BG102064A (en) Method for increasing the retinal blood circulation
NO943734D0 (no) Brönnfluidadditiv, fremgangsmåte for behandling av brönnfluid, og fremgangsmåte for behandling av brönnutstyr
HU9700598D0 (en) Process for profilacting and treating pancreatitis
NO914885L (no) Fremgangsmaate for utvinning av mikrobiologisk produsert chymosin
EA199800816A1 (ru) Способы лечения и профилактики интерстициального цистита
WO2001087239A3 (en) Methods of affecting laminin 5 processing
DE69922364D1 (de) Verfahren zur immunisierung und behandlung von h. pylori infektion
ZA965346B (en) Methods of treating neuropeptide Y-associated conditions.
ATE266395T1 (de) Glycin zur vorbeugung oder behandlung von transplantatabstossungen
SE9301606D0 (sv) Composition for the treatment of impaired hair growth

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU